Prostate cancer is the second highest incidence and mortality in the world, but advances in early diagnosis have achieved a potential cure rate of up to 90%. This improvement has special relevance protein marker of prostate specific antigen (PSA), whose analysis can diagnose prostate-related advance even to the manifestation of disease symptoms.
Latest developments in treatment and diagnosis of prostate cancer have the great role in the techniques in surgery in the treatment of this disease. One of the biggest innovations has been the radical prostatectomy, laparoscopic and robotic, which provides improvements in urinary continence and sexual potency. The incorporation of new drugs and molecules has improved significantly the quality of life and survival of patients in advanced stages of the disease.
Both the detection and monitoring of prostate cancer imaging techniques are configured as the key tool of a biopsy oriented fusion future. It combines the information provided by ultrasound, more accurate, and multiparameter resonance, which provides morphological and functional information of the prostate.